• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Cytoplasmic EBP50 and elevated PARP1 are unfavorable prognostic factors in ovarian clear cell carcinoma

Research Project

Project/Area Number 20K07397
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 49020:Human pathology-related
Research InstitutionKitasato University

Principal Investigator

Matsumoto Toshihide  北里大学, 医療衛生学部, 講師 (10623184)

Project Period (FY) 2020-04-01 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2022: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2021: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2020: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Keywords卵巣明細胞癌 / プロテオーム / EBP50 / PARP1 / 抗癌剤耐性 / プロテオミクス / 抗癌剤耐性能 / 新規バイオマーカー / ショットガンプロテオミクス
Outline of Research at the Start

卵巣明細胞癌(OCCCa)は抗癌剤療法に低感受性で進行・再発癌の患者予後は極めて不良である。研究代表者は網羅的タンパク質発現解析により、再発OCCCa例ではEBP50が高発現することを見出した。その後の先行研究結果を集約して、「OCCCaにおいて、EBP50はPI3K/Aktシグナルにより核内へ移行し、PARP-1と協調してDNA修復とアポトーシス回避を促進する。その結果、腫瘍再発・抗癌剤耐性能獲得に寄与する。故に、OCCCaにおけるEBP50をターゲットにした新規分子標的治療法開発の分子基盤構築に繋がる」との作業仮説の立案に至った。本研究はこの仮説を立証し、OCCCa患者の予後改善を目指す。

Outline of Final Research Achievements

Patients with ovarian clear cell carcinoma (OCCC) experience frequent recurrence, which is most likely due to chemoresistance. We used shotgun proteomics analysis and identified upregulation of EBP50 in recurrent OCCC samples. Abrogation of resistance following knockdown of EBP50 was accompanied by increased apoptotic cells. We found that PARP1, which is involved in DNA damage detection and repair, binds to EBP50 through its PDZ1 domain. Cisplatin treatment of cells expressing EBP50 increased nuclear PARP1 expression, whereas knockdown of EBP50 cells decreased PARP1 expression and activity following Cisplatin treatment. Finally, OCCC patients with a combination of EBP50 and high PARP1 score had worst the prognosis for overall and progression-free survival.

Academic Significance and Societal Importance of the Research Achievements

本研究で用いたホルマリン固定パラフィン包埋検体のショットガンプロテオミクス法による網羅的解析は、我々のグループ独自の解析手法である。本法によりOCCCの再発・予後を規定する候補因子としてEBP50を見出し、国内外を通じて、OCCCにおけるEBP50発現とその機能解析は殆ど手付かずの状態であり、極めて独自性の高い研究である。小分子化合物等を用いたEBP50シグナル系阻害による新規治療法の分子基盤を築くことができる。特に、本分子を標的とした治療法は、再発例や標準治療に抵抗性を示すOCCCに対しても有効であることが想定され、患者予後改善に著しく貢献できることが期待できる。

Report

(5 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2022 Research-status Report
  • 2021 Research-status Report
  • 2020 Research-status Report
  • Research Products

    (25 results)

All 2024 2023 2022 2021 2020

All Journal Article (16 results) (of which Int'l Joint Research: 2 results,  Peer Reviewed: 16 results,  Open Access: 10 results) Presentation (9 results)

  • [Journal Article] Immunoglobulin G4-related thyroiditis associated with Graves’ disease: A case report2024

    • Author(s)
      Takahashi Hiroyuki、Kajita Sabine、Katoh Hiroshi、Matsumoto Toshihide、Inoue Akemi、Sangai Takafumi、Saegusa Makoto
    • Journal Title

      Heliyon

      Volume: 10 Issue: 4 Pages: e25843-e25843

    • DOI

      10.1016/j.heliyon.2024.e25843

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Nucleobindin-2 mediates TGF-beta1-driven phenotypes in ZEB1-high uterine carcinosarcoma2023

    • Author(s)
      Yui Kobayashi , Ako Yokoi , Miki Hashimura, Yasuko Oguri, Ryo Konno, Toshihide Matsumoto, Masataka Tochimoto, Mayu Nakagawa, Yu Ishibashi, Takashi Ito, Kensuke Ohhigata, Yohei Harada, Naomi Fukagawa, Yoshio Kodera, Makoto Saegusa
    • Journal Title

      Am J Pathol

      Volume: 193 Issue: 8 Pages: 1116-1128

    • DOI

      10.1016/j.ajpath.2023.04.011

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma2023

    • Author(s)
      Nakagawa Mayu、Matsumoto Toshihide、Yokoi Ako、Hashimura Miki、Oguri Yasuko、Konno Ryo、Ishibashi Yu、Ito Takashi、Ohhigata Kensuke、Harada Yohei、Fukagawa Naomi、Kodera Yoshio、Saegusa Makoto
    • Journal Title

      Molecular Oncology

      Volume: 17 Issue: 10 Pages: 2168-2182

    • DOI

      10.1002/1878-0261.13503

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Anaplastic lymphoma kinase overexpression enhances aggressive phenotypic characteristics of endometrial carcinoma2023

    • Author(s)
      Yokoi A, Nakamura Y, Hashimura M, Oguri Y, Matsumoto T, Nakagawa M, Ishibashi Y, Ito T, Ohhigata K, Harada Y, Fukagawa N, Saegusa M.
    • Journal Title

      BMC Cancer

      Volume: 23 Issue: 1 Pages: 765-765

    • DOI

      10.1186/s12885-023-11144-2

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Functional interaction between S100A1 and MDM2 may modulate p53 signaling in normal and malignant endometrial cells2022

    • Author(s)
      Nakagawa M, Higuchi S, Hashimura M, Oguri Y, Matsumoto T, Yokoi A, Ishibashi Y, Ito T, Saegusa M
    • Journal Title

      BMC Cancer

      Volume: 22 Issue: 1 Pages: 184-184

    • DOI

      10.1186/s12885-022-09249-1

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] A functional role of S100A4/non-muscle myosin IIA axis for pro-tumorigenic vascular functions in glioblastoma2022

    • Author(s)
      Madoca Inukai
    • Journal Title

      Cell Commun Signal .

      Volume: Apr 7;20(1) Issue: 1 Pages: 46-46

    • DOI

      10.1186/s12964-022-00848-w

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] A combination of stromal <scp>PD‐L1</scp> and tumoral nuclear β‐catenin expression as an indicator of colorectal carcinoma progression and resistance to chemoradiotherapy in locally advanced rectal carcinoma2022

    • Author(s)
      Takahashi Hiroyuki、Watanabe Hirono、Hashimura Miki、Matsumoto Toshihide、Yokoi Ako、Nakagawa Mayu、Ishibashi Yu、Ito Takashi、Ohhigata Kensuke、Saegusa Makoto
    • Journal Title

      The Journal of Pathology: Clinical Research

      Volume: 8 Issue: 5 Pages: 458-469

    • DOI

      10.1002/cjp2.285

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] PTEN overexpression and nuclear β-catenin stabilization promote morular differentiation through induction of epithelial?mesenchymal transition and cancer stem cell-like properties in endometrial carcinoma2022

    • Author(s)
      Yokoi Ako、Minami Marina、Hashimura Miki、Oguri Yasuko、Matsumoto Toshihide、Hasegawa Yoshinori、Nakagawa Mayu、Ishibashi Yu、Ito Takashi、Ohhigata Kensuke、Harada Youhei、Fukagawa Naomi、Saegusa Makoto
    • Journal Title

      Cell Communication and Signaling

      Volume: 20 Issue: 1 Pages: 181-181

    • DOI

      10.1186/s12964-022-00999-w

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] TP53 positivity combined with high fibrinogen expression defines a subtype of oral squamous cell carcinoma with an unfavorable prognosis2022

    • Author(s)
      Inoue Akemi、Matsumoto Toshihide、Ito Yuka、Saegusa Makoto、Takahashi Hiroyuki
    • Journal Title

      Human Pathology

      Volume: 130 Pages: 25-35

    • DOI

      10.1016/j.humpath.2022.10.008

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Increased nerve growth factor expression in the synovial tissues of patients with rotator cuff tears2021

    • Author(s)
      Tazawa Ryo、Kenmoku Tomonori、Uchida Kentaro、Arendt-Nielsen Lars、Nagura Naoshige、Nakawaki Mitsufumi、Matsumoto Toshihide、Inoue Gen、Takeuchi Hiroto、Jimbo Takenori、Nakazawa Toshiyuki、Fukuda Michinari、Takaso Masashi
    • Journal Title

      Molecular Pain

      Volume: 17

    • DOI

      10.1177/17448069211021252

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Anaplastic Lymphoma Kinase Overexpression Is Associated with Aggressive Phenotypic Characteristics of Ovarian High-Grade Serous Carcinoma2021

    • Author(s)
      Matsumoto T, Oda Y, Hasegawa Y, Hashimura M, Oguri Y, Inoue H, Yokoi A, Tochimoto M, Nakagawa M, Jiang Z, Saegusa M.
    • Journal Title

      Am J Pathol

      Volume: 191 Issue: 10 Pages: 1837-1837

    • DOI

      10.1016/j.ajpath.2021.06.009

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Cytoplasmic EBP50 and elevated PARP1 are unfavorable prognostic factors in ovarian clear cell carcinoma2021

    • Author(s)
      Matsumoto Toshihide、Yoki Ako、Konno Ryo、Oguri Yasuko、Hashimura Miki、Tochimoto Masataka、Nakagawa Mayu、Jiang Zesong、Ishibashi Yu、Ito Takashi、Kodera Yoshio、Saegusa Makoto
    • Journal Title

      Carcinogenesis

      Volume: 42 Issue: 9 Pages: 1162-1170

    • DOI

      10.1093/carcin/bgab070

    • Related Report
      2021 Research-status Report
    • Peer Reviewed
  • [Journal Article] Regulation of tumor necrosis factor-alpha by peptide Lv in bone marrow macrophage and synovium2021

    • Author(s)
      3.Mukai M, Uchida K. Okubo T, Takano S, Matsumoto T, Satoh M, Inoue G, Takaso M
    • Journal Title

      Frontiers in Medicine Rheumatology

      Volume: 8 Pages: 701216-701216

    • DOI

      10.3389/fmed.2021.702126

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Requirements of LEFTY and Nodal overexpression for tumor cell survival under hypoxia in glioblastoma2020

    • Author(s)
      Matsumoto Toshihide、Chino Hiromi、Akiya Masashi、Hashimura Miki、Yokoi Ako、Tochimoto Masataka、Nakagawa Mayu、Jiang Zesong、Saegusa Makoto
    • Journal Title

      Molecular Carcinogenesis

      Volume: 59 Issue: 12 Pages: 1409-1419

    • DOI

      10.1002/mc.23265

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma2020

    • Author(s)
      Hiruta Ai、Oguri Yasuko、Yokoi Ako、Matsumoto Toshihide、Oda Yusuke、Tomohiro Mikihisa、Hashimura Miki、Jiang Zesong、Tochimoto Masataka、Nakagawa Mayu、Saegusa Makoto
    • Journal Title

      The American Journal of Pathology

      Volume: 190 Issue: 11 Pages: 2304-2316

    • DOI

      10.1016/j.ajpath.2020.07.014

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Upregulation of fibronectin following loss of p53 function is a poor prognostic factor in ovarian carcinoma with a unique immunophenotype2020

    • Author(s)
      Yokoi Ako、Matsumoto Toshihide、Oguri Yasuko、Hasegawa Yoshinori、Tochimoto Masataka、Nakagawa Mayu、Saegusa Makoto
    • Journal Title

      Cell Communication and Signaling

      Volume: 18 Issue: 1 Pages: 103-103

    • DOI

      10.1186/s12964-020-00580-3

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] 卵巣漿液癌におけるALK発現は 腫瘍高悪性度化と予後に寄与する2023

    • Author(s)
      松本俊英、小田祐介、長谷川嘉則、橋村美紀、小栗康子、井上久子、横井愛香、三枝信
    • Organizer
      第112回日本病理学会総会
    • Related Report
      2023 Annual Research Report
  • [Presentation] 再発卵巣明細胞癌におけるEBP50/PARP1系は化学療法耐性能と予後に寄与する2023

    • Author(s)
      松本俊英、横井愛香、紺野亮、小栗康子、橋村美紀、中川茉祐、小寺義男、三枝
    • Organizer
      日本プロテオーム学会2023年大会
    • Related Report
      2023 Annual Research Report
  • [Presentation] 卵巣明細胞癌においてcytoplasmic EBP50/PARP-1は抗癌剤耐性能獲得に寄与する2022

    • Author(s)
      松本俊英、横井愛香、紺野亮、小栗康子、橋村美紀、中川茉祐、小寺義男、三枝信
    • Organizer
      第111回日本病理学会総会
    • Related Report
      2022 Research-status Report
  • [Presentation] Research on mechanisms of carcinogenesis and chemo-resistance in ovarian clear cell carcinoma2022

    • Author(s)
      Toshihide Matsumoto
    • Organizer
      The 111th Annual Meeting of the Japanese Society of Pathology. Award Lecture
    • Related Report
      2022 Research-status Report
  • [Presentation] 卵巣明細胞癌においてEBP50/PARP-1 axisは抗癌剤耐性能獲得に寄与する2021

    • Author(s)
      松本俊英、横井愛香、紺野亮、小寺義男、三枝信
    • Organizer
      第110回日本病理学会総会
    • Related Report
      2021 Research-status Report
  • [Presentation] 卵巣明細胞癌における臨床応用に向けた新規バイオマーカー探索とその機能解析2021

    • Author(s)
      松本俊英、秋谷昌史、川島祐介、小寺義男、小栗康子、橋村美紀、三枝信
    • Organizer
      日本プロテオーム学会2021大会
    • Related Report
      2021 Research-status Report
  • [Presentation] 卵巣明細胞癌の新規バイオマーカー探索とその機能解析:病理検体を用いたショットガンプロテオミクス法2021

    • Author(s)
      松本俊英、川島祐介、紺野亮、小寺義男、横井愛香、秋谷昌史、小栗康子、橋村美紀、三枝信
    • Organizer
      第72回日本電気泳動学会総会
    • Related Report
      2021 Research-status Report
  • [Presentation] 病理検体を用いた卵巣明細胞癌の新規バイオマーカー探索:Leftyの同定とその臨床的意義の検討2020

    • Author(s)
      松本俊英, 秋谷昌史, 川島祐介, 小寺義男, 横井愛香, 小栗康子, 橋村美紀, 三枝信
    • Organizer
      第71回日本電気泳動学会総会
    • Related Report
      2020 Research-status Report
  • [Presentation] EBP50は卵巣明細胞癌の再発・予後不良因子である2020

    • Author(s)
      松本俊英、横井愛香、紺野亮、小寺義男、三枝信
    • Organizer
      第109回日本病理学会総会
    • Related Report
      2020 Research-status Report

URL: 

Published: 2020-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi